Recap: Enanta Pharma Q1 Earnings

Enanta Pharma ENTA reported its Q1 earnings results on Wednesday, February 7, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.

Enanta Pharma missed estimated earnings by 32.77%, reporting an EPS of $-1.58 versus an estimate of $-1.19.

Revenue was down $5.58 million from the same period last year.

Last quarter the company beat on EPS by $0.67 which was followed by a 11.52% increase in the share price the next day.

Here's a look at Enanta Pharma's past performance:

Quarter	Q4 2023	Q3 2023	Q2 2023	Q1 2023
EPS Estimate	-2	-2.33	-1.98	-1.59
EPS Actual	-1.33	-1.86	-1.79	-1.39
Revenue Estimate	17.50M	18.06M	19.18M	22.57M
Revenue Actual	18.93M	18.89M	17.80M	23.59M

To track all earnings releases for Enanta Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar